157 related articles for article (PubMed ID: 811925)
1. [Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)].
Baumeister G; Wagner H; Stahl M
Klin Wochenschr; 1975 Jun; 53(12):571-4. PubMed ID: 811925
[TBL] [Abstract][Full Text] [Related]
2. Modulation of A and B cell functions by tolbutamide and arginine in the pancreas of thiamine-deficient rats.
Rathanaswami P; Sundaresan R
Biochem Int; 1989 Oct; 19(4):793-802. PubMed ID: 2695088
[TBL] [Abstract][Full Text] [Related]
3. Sulphonylurea (glubenclamide) enhances somatostatin and inhibits glucagon release induced by arginine.
Efendić S; Enzmann F; Nylén A; Uvnäs-Wallensten K; Luft R
Acta Physiol Scand; 1980 Mar; 108(3):231-3. PubMed ID: 6103639
[TBL] [Abstract][Full Text] [Related]
4. Suppression of pancreatic glucagon release by the hypoglycaemic sulphonylureas.
Samols E; Tyler JM; Mialhe P
Lancet; 1969 Jan; 1(7587):174-6. PubMed ID: 4178416
[No Abstract] [Full Text] [Related]
5. Secretion of glucagon and insulin in hypophysectomized rats: effect of tolbutamide.
Dunbar JC; Walsh MF; Foà PP
Horm Res; 1979; 11(2):81-91. PubMed ID: 383597
[TBL] [Abstract][Full Text] [Related]
6. Chronic exposure to tolbutamide and glibenclamide impairs insulin secretion but not transcription of K(ATP) channel components.
Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
Pharmacol Res; 2004 Jul; 50(1):41-6. PubMed ID: 15082027
[TBL] [Abstract][Full Text] [Related]
7. Suppression of pancreatic glucagon secretion by tolbutamide in dogs.
Ohneda A; Sato M; Matsuda K; Itabashi H; Horigome K; Chiba M; Yamagata S
Horm Metab Res; 1974 Nov; 6(6):478-83. PubMed ID: 4452546
[No Abstract] [Full Text] [Related]
8. [In vivo and in vitro study of tolbutamide, a hypoglycemic sulfamide: effects on pancreatic glucagon secretion].
Loubatières A; Loubatières-Mariani MM; Alric R; Ribes G
C R Acad Hebd Seances Acad Sci D; 1973 Jan; 276(3):427-31. PubMed ID: 4197496
[No Abstract] [Full Text] [Related]
9. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide.
Ball AJ; Flatt PR; McClenaghan NH
Eur J Pharmacol; 2000 Nov; 408(3):327-33. PubMed ID: 11090651
[TBL] [Abstract][Full Text] [Related]
10. Effect of sulfonylureas on the secretion of pancreatic immunoreactive glucagon and enteric glucagon-like immunoreactivity.
Crockford PM; Powell P; Addah SA
Can J Physiol Pharmacol; 1973 Dec; 51(12):990-2. PubMed ID: 4204715
[No Abstract] [Full Text] [Related]
11. Effects of hypoglycemic sulfonamides on glucagon and insulin secretion in ducks and dogs.
Kajinuma H; Kuzuya TT; Ide T
Diabetes; 1974 May; 23(5):412-7. PubMed ID: 4208464
[No Abstract] [Full Text] [Related]
12. Effects of endotoxin and interleukin-1 on glucagon and insulin secretion from the perfused rat pancreas.
Yelich MR
Pancreas; 1992; 7(3):358-66. PubMed ID: 1594558
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat.
Silvestre RA; Miralles P; Moreno P; Villanueva ML; Marco J
Biochem Biophys Res Commun; 1986 Feb; 134(3):1291-7. PubMed ID: 2868720
[TBL] [Abstract][Full Text] [Related]
14. [Effect of tolbutamide and glibenclamide on glucagon secretion in subjects with normal metabolism and in diabetics].
Baumeister G; Zierden E; Wagner H; Stahl M
Verh Dtsch Ges Inn Med; 1975; 81():1484-6. PubMed ID: 818838
[No Abstract] [Full Text] [Related]
15. Early insulin and glucagon response to subsequent pulses of arginine, glucose, and tolbutamide in normal man.
Greco AV; Manna R; Ghirlanda G; Altomonte L; Rebuzzi AG; Bertoli A
Am J Physiol; 1979 Feb; 236(2):E85-9. PubMed ID: 369391
[TBL] [Abstract][Full Text] [Related]
16. In vitro secretion of insulin after glucose, sulphonylureas, adrenergic and cholinergic substances studied by isolated perfused rat pancreas.
Loubatières A; Loubatières-Mariani MM
Endocrinol Exp; 1974 Jun; 8(2):75-87. PubMed ID: 4209693
[No Abstract] [Full Text] [Related]
17. Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.
Marco J; Valverde I
Diabetologia; 1973 Sep; ():317-9. PubMed ID: 4204092
[No Abstract] [Full Text] [Related]
18. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
19. Effects of galanin on hormone secretion from the in situ perfused rat pancreas and on glucose production in rat hepatocytes in vitro.
Silvestre RA; Miralles P; Monge L; Moreno P; Villanueva ML; Marco J
Endocrinology; 1987 Jul; 121(1):378-83. PubMed ID: 2439313
[TBL] [Abstract][Full Text] [Related]
20. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
Haupt E; Beyer J; Schöffling K
Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
